Jonathan Biller
At a glance: Jonathan Biller is General Counsel at Vertex Pharmaceuticals (VRTX). Their latest SEC Form 4, filed Feb 26, 2026, reported a sale of $460K. On file: 0 purchase lines ($0) and 7 sale lines ($4.1M).
Disclosed holdings: about $7.1M of VRTX stock: 13,659 shares reported on their latest Form 4 (filed Feb 26, 2026), valued at the Nov 19, 2026 close of $521.30. This counts only VRTX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
General Counsel at Vertex Pharmaceuticals Inc / Ma (VRTX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Jonathan Biller's InsiderPrint
7 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 7 times a year, typically $493K a trade; most sales are on a pre-planned 10b5-1 schedule; trades in the same month most years.
- Bump outward: a purchase (0)
- Dent inward: a sale (7)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Jennifer WuamettGeneral Counsel · NXPI · 100% match
- Joseph H. WenderDirector · IONS · 100% match
- Joseph ShulmanChief Technical Officer · RYTM · 100% match
- Joseph Anthony Mara Jr.CFO · VCEL · 100% match
- Mark Andrew SmithCFO · CMI · 100% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Feb 26SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 94513,659 held (−6%) | $486.35 | $460K | +7.2% |
| Feb 19SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 2,47616,992 held (−13%) | $489.46 | $1.2M | +6.5% |
| Feb 19SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 1,24415,748 held (−7%) | $473.68 | $589K | +10.1% |
| Feb 18SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 98816,838 held (−6%) | $499.00 | $493K | +4.5% |
| Feb 12SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 1,92520,819 held (−8%) | $460.43 | $886K | +13.2% |
| Dec 5SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 34715,306 held (−2%) | $449.00 | $156K | +16.1% |
| Oct 3SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 69415,653 held (−4%) | $404.21 | $281K | +29.0% |
- Sell
General Counsel Jonathan Biller sold $460K of VRTX at $486.35 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Jonathan Biller sold $1.2M of VRTX at $489.46 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Jonathan Biller sold $589K of VRTX at $473.68 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Jonathan Biller sold $493K of VRTX at $499.00 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Jonathan Biller sold $886K of VRTX at $460.43 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Jonathan Biller sold $156K of VRTX at $449.00 — pre-scheduled 10b5-1 plan sale.
Follow Jonathan Biller
Get one email when Jonathan Biller files a new purchase or sale. Free.
At most one email a day about Jonathan Biller, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.